These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
130 related items for PubMed ID: 8055006
1. Implementing a cancer-control study in a National Cancer Institute clinical trials network. Labuhn KT, Valanis BG, Glass AG, Vollmer WM. Cancer Pract; 1994; 2(1):47-54. PubMed ID: 8055006 [Abstract] [Full Text] [Related]
2. The NCI All Ireland Cancer Conference. Johnston PG, Daly PA, Liu E. Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862 [Abstract] [Full Text] [Related]
3. Using a community cancer treatment trials network for cancer prevention and control research: challenges and opportunities. Kaluzny AD, Lacey LM, Warnecke R, Morrissey JP, Sondik E, Ford L. Cancer Epidemiol Biomarkers Prev; 1994; 3(3):261-9. PubMed ID: 8019377 [Abstract] [Full Text] [Related]
4. Research-design issues in cancer-symptom-management trials using complementary and alternative medicine: lessons from the National Cancer Institute Community Clinical Oncology Program experience. Buchanan DR, White JD, O'Mara AM, Kelaghan JW, Smith WB, Minasian LM. J Clin Oncol; 2005 Sep 20; 23(27):6682-9. PubMed ID: 16170176 [Abstract] [Full Text] [Related]
5. Performance in quasi-firms: an example from the Community Clinical Oncology Program. Lacey LM, Hynes DM, Kaluzny AD. J Health Hum Resour Adm; 1992 Sep 20; 14(3):307-26. PubMed ID: 10118501 [Abstract] [Full Text] [Related]
6. Adapting clinical trials networks to promote cancer prevention and control research. Weiner BJ, McKinney MM, Carpenter WR. Cancer; 2006 Jan 01; 106(1):180-7. PubMed ID: 16333855 [Abstract] [Full Text] [Related]
7. Predicting the performance of a strategic alliance: an analysis of the Community Clinical Oncology Program. Kaluzny AD, Lacey LM, Warnecke R, Hynes DM, Morrissey J, Ford L, Sondik E. Health Serv Res; 1993 Jun 01; 28(2):159-82. PubMed ID: 8514498 [Abstract] [Full Text] [Related]
8. The effects of managed care and competition on community-based clinical research. Carpenter WR, Weiner BJ, Kaluzny AD, Domino ME, Lee SY. Med Care; 2006 Jul 01; 44(7):671-9. PubMed ID: 16799362 [Abstract] [Full Text] [Related]
9. Community Clinical Oncology Program participation in the Breast Cancer Prevention Trial: factors affecting accrual. Klabunde C, Kaluzny A, Ford L. Cancer Epidemiol Biomarkers Prev; 1995 Jul 01; 4(7):783-9. PubMed ID: 8672997 [Abstract] [Full Text] [Related]
10. Cancer control research for community programs: the National Cancer Institute initiative. Hunter CP, Bavier AR, Ford LG. Cancer Detect Prev; 1990 Jul 01; 14(6):633-7. PubMed ID: 2257561 [Abstract] [Full Text] [Related]
14. Continued challenges with the use of erythropoiesis-stimulating agents in patients with cancer: perspectives and issues on policy-guided health care. Arbuckle RB, Griffith NL, Iacovelli LM, Johnson PE, Jorgenson JA, Kloth DD, Lucarelli CD, Muller RJ. Pharmacotherapy; 2008 May 01; 28(5 Pt 2):1S-15S. PubMed ID: 18447704 [Abstract] [Full Text] [Related]